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ABSTRACT 
 
INTRODUCTON 
There remains no „gold standard‟ for the diagnosis of carpal tunnel syndrome (CTS). 
Clinical diagnosis is often held to be paramount but depends on the skills of the 
individual practitioner. This paper describes two mathematical approaches to the 
analysis of a history obtained from the patient by questionnaire. 
 
METHODS 
We used two previously published instruments and two new ones, one conventional 
logistic regression analysis and one articifical neural network, to analyse data from a 
population of 5860 patients referred for diagnosis of hand symptoms and evaluated 
their ability to predict whether nerve conduction studies would confirm the diagnosis 
of CTS using receiver operating characteristic curves 
 
RESULTS 
Both of the new instruments performed better than the existing tools achieving 
sensitivity of 88% and specificity of 50% in predicting abnormal median nerve 
conduction at the carpal tunnel. When combined 96% sensitivity and 50% specificity 
were achieved 
 
DISCUSSION 
The combined instrument performs well enough to be used as a preliminary screening 
tool for CTS, for self-diagnosis by the patient and as a supplement to diagnosis in 
primary care. 
 
Keywords 
 
Carpal tunnel syndrome 
 
Diagnosis 
 
Questionnaire 
 
Neural Networks 
 
Nerve Conduction Studies 
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INTRODUCTION 
 
Although there is general agreement about what clinical features are indicative of 
CTS, there is no internationally agreed definition and though it is easy to recognise a 
typical case clinically there are many patients with atypical symptoms, some of whom 
may benefit from treatment. The definitive treatment is surgical decompression, a 
procedure which is mostly very successful, but which results in a small incidence of 
significant morbidity. It is thus important that patients who could benefit from surgery 
are identified as accurately as possible. 
 
Several attempts have been made at formalising diagnostic criteria for CTS. Some are 
simply the opinion of an expert in the field, creating a definition for the purposes of a 
particular study. Clinically definite CTS in one Scandinavian study was defined as 
“Recurring night-time or activity related numbness or tingling involving the palmar 
aspects of at least two radial fingers”1. A definition for use in epidemiological studies 
and occupational health surveillance was proposed in 1998 – “A clinical syndrome 
caused by compression of the median nerve as it passes through the carpal tunnel: 
Surveillance criteria - Pain or paraesthesia, or sensory loss in the median nerve 
distribution and one of: Tinel's test positive, Phalen's test positive, nocturnal 
exacerbation of symptoms, motor loss with wasting of abductor pollicis brevis, and 
abnormal conduction time.”2 This makes it explicit that CTS is a condition which 
results from a particular pathological process at a specified site, and it allows the 
inclusion of a laboratory measurement (NCS) as a supplementary diagnostic criterion. 
These diagnostic criteria are not intended for making treatment decisions in the 
individual patient and err on the side of inclusivity rather than diagnostic specificity. 
No single clinical feature, such as Phalen‟s sign, is sufficient to make the diagnosis, 
and the syndrome cannot be defined solely by a laboratory measurement such as NCS. 
 
An alternative to expert opinion is provided by mathematical approaches based upon 
the study of the degree of association between clinical features and diagnosis. For any 
clinical feature which is either present or absent the association with the diagnosis can 
be expressed as sensitivity and specificity, or positive and negative predictive values. 
Clinical diagnosis however depends on the synthesis of many items of information 
about the patient and mathematical methods also exist for this.  
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Logistic regression is a statistical technique, widely used in the health sciences,3,4 for 
estimating the probability of a disease being present in a patient, based on the values 
of several covariates.  In order to convert the probability of a disease to a diagnosis, 
the simplest approach is to use a cutpoint, c: if the probability of the disease is at most 
c, then the diagnosis based on the logistic model is “disease absent”; otherwise, the 
diagnosis is “disease present”.  Failing any evidence to the contrary, the usual value of 
c is 0.5.  Estimation of the logistic regression model requires iterative statistical 
methods, since the equations involved do not have an exact solution.  The simplest 
method of evaluating the performance of the logistic regression model is to split the 
dataset (if sufficiently large), containing the values of the covariates and the “true” 
diagnosis, into two similar but disjoint training and test subsets, fitting the model to 
the training subset and testing it on the test subset.   
 
Artificial neural networks (ANNs) are classifier systems, based on simplified models 
of the cerebral system, that  have been applied to a number of clinical applications.5 
The basic ANN processing unit is a node which operates in a similar way to the 
biological neuron. A number of nodes are combined in interconnected layers to 
process information. Importantly ANNs can be trained to classify data for a specific 
task. The popular method, applied in this work, is to construct two independent 
datasets containing a matched set of inputs and  outputs. Through repeated 
presentation of the first dataset the ANN internal parameters  are gradually adjusted to 
minimise the error between  obtained and expected outputs. When this stage is 
complete the second dataset tests the ability of the trained ANN to classify unknown 
data. If this result is acceptable the ANN can be used to classify new cases. 
 
The use of clinical questionnaires in CTS is not new. One of the earliest and most 
widely used examples is the CTS severity instrument devised as a measure of 
subjective symptom severity and functional impairment by Levine et al in 1993.6 
Attempts have been made to use this for diagnostic purposes, with limited success.7,8 9 
Other similar tools have not gained such widespread acceptance.10-12 The earliest 
formal tool designed to aid diagnosis is the Katz hand diagram.13 We have previously 
published an instrument which combines 8 variables which can be obtained from the 
patient without any intervention from a clinical professional to provide an overall 
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probability of CTS.14 One other diagnostic questionnaire based purely on data derived 
form the patient history has been proposed15 and three which include data derived 
from physical examination, the CTS-7 instrument from Ontario.16 and two un-named 
tools.17,18 
 
In the absence of any „gold standard‟ with which to compare, it is impossible to 
measure the performance of a prototype tool with complete accuracy and in order to 
create a logistic regression model or an ANN one has to make an arbitrary choice of 
how to divide the population of patients used to calculate the coefficients into CTS 
and non-CTS cases. Three existing tools 14-16 demonstrate different approaches. 
 
Our own earlier model defined cases for model generation only by the results of nerve 
conduction studies and is therefore optimised to predict whether the NCS will be 
abnormal rather than whether the patient has CTS. This instrument achieves 76% 
sensitivity and 70% specificity in predicting abnormal NCS. A modified version of 
this has been used in Glasgow where it achieved 82% sensitivity and 67% 
specificity.19 A Brazilian regression model achieved 67% sensitivity and 69% 
specificity.17 
 
Kamath and Stothard15 used the clinical response to surgical decompression as the 
marker for CTS, patients reporting a good response to surgery 2 weeks after operation 
being assumed to have CTS. The method used to arrive at the questions included in 
the questionnaire and their weightings is not explicit. This instrument was reported to 
achieve 85% sensitivity, compared with 92% for NCS, in predicting a successful 
outcome for surgery. No data is available for diagnostic specificity. The use of 
surgical outcome as a proxy for the diagnosis is appealing as the decision to be made 
is primarily whether to operate and anything which accurately predicts the response to 
surgery would be very useful. However, as a gold standard for diagnosis, surgical 
response has some shortcomings. Other disorders may improve symptomatically in 
response to surgery and the associated rest and recovery period and failure to respond 
to surgery does not necessarily indicate that the original problem was not CTS.  
 
The clinical features used in the CTS-7 were compiled through a Delphi consensus 
development process by a group of „CTS-experts‟ and a logistic regression model 
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derived using a set of fictitious clinical vignettes including all of the features which 
had featured in the original list from the Delphi exercise in roughly equal proportions 
and every possible combination. Each vignette was classified as representative of CTS 
or not by a second, independent, panel of experts. This tool was thus created and 
weighted without reference to any patient population, both development and 
validation being against expert opinion. 
 
We report here an updated version of our original diagnostic tool using traditional 
regression methods and also used an artificial neural network system with the same 
input data as an example of an alternative computational approach. 
 
METHODS 
 
The Canterbury Carpal Tunnel Database contains computerised clinical data on 
almost all patients presenting to medical attention with suspected carpal tunnel 
syndrome in a geographical area with a population of 700,000 people. All clinicians 
dealing with the problem are encouraged to refer every patient in whom the diagnosis 
is considered for nerve conduction studies with the intent that all patients should be 
captured and tested. As a result of this inclusive policy, nerve conduction studies are 
performed on a substantial number of patients who do not in fact have CTS and the 
database consists of approximately 60% patients with abnormal NCS consistent with 
CTS and 40% patients without such results. Although these two patient groups will 
include both false negative and false positive NCS tests it is likely that the majority of 
patients in the NCS-positive group do have CTS and the majority in the NCS-negative 
group do not. 
 
We abstracted anonymised patient data collected during the period 2000-2007 from 
5280 subjects, and divided this into subsets to be used for model generation and 
testing. Most of the data required to complete the Kamath questionnaire and the CTS-
7 instrument is also stored in the database but we did not routinely record the presence 
of symptoms during a previous pregnancy or neck pain in the core data set so these 
were added prospectively for a further cohort of patients to allow evaluation of the 
performance of the Kamath tool in this population. The CTS-7 includes examination 
findings (Tinel‟s and/or Phalen‟s signs) and we wished to study data which could be 
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collected from the patient without medical intervention. Only patients making their 
first presentation with possible CTS were included, excluding those with previous 
surgery to either side or recurrence after successful conservative treatment. We did 
not exclude patients with concomitant pathologies such as diabetic polyneuropathy or 
ulnar neuropathy as we wished the results to be as generalisable as possible to normal 
practice.  
 
The same model generation dataset was presented to both the neural network software 
(NeuralWorks Professional, Neuralware, Pennsylvania) and to a logistic regression 
analysis system (Stata, StataCorp LP, Texas). In the model generation dataset, cases 
were defined as „CTS‟ if the nerve conduction results were abnormal suggestive of 
CTS in either or both hands and as „not-CTS‟ if both hands had normal NCS. The 
resulting models were then applied to new data from the test set to measure their 
performance in predicting CTS or not-CTS. 
 
Nerve conduction studies were carried out on both hands of all patients to AANEM 
standards.  
 
RESULTS 
 
All of the methods proved able to classify new cases as CTS or Non-CTS with a 
performance better than chance. An overall comparison of their performance is shown 
in figure 1 as receiver operating characteristic curves from which it can be seen that 
the artificial neural network and logistic regression are virtually indistinguishable 
from each other, and better than the previous logistic regression, which in turn is 
better than the Kamath score. Both our neural network and regression models are built 
using an inclusive policy involving 125 variables which provides every piece of 
clinical information available to the model for decision making. We did not employ 
methods for simplifying the regression model because we wanted to maintain close 
comparability with the neural network. Features with the largest positive and negative 
weightings are shown in table 1. In order to express the performance of these tools in 
terms of sensitivity and specificity one has to choose one point on the ROC curve as a 
cut-off value and it is conventional to optimise this choice for overall accuracy as the 
point at the greatest perpendicular distance from the diagonal line which represents a 
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test with no discriminating ability. For our models this point falls at a score of 0.55 for 
the artificial neural network and 0.63 for the regression model. The exact value used 
for a cutoff will depend to some extent on clinical circumstances. When screening for 
possible cases a lower cut-point would trade off some specificity in return for greater 
sensitivity while for identifying clinically certain cases for a trial a higher cut-point 
yields only patients with highly probable CTS but excludes more clinically atypical 
cases. Using values optimised for overall accuracy the sensitivity and specificity of 
the two approaches are shown in table 2. Finally, as each model identifies a slightly 
different subset of patients as having CTS, we looked at the combined performance 
obtained if a patient was classified using the output of both models, classifying as 
CTS if either or both models predicted CTS and as non-CTS only if both models 
predict non-CTS. The sensitivity and specificity of this combined approach are shown 
in table 3. 
 
DISCUSSION 
 
There are points of similarity and dissimilarity between the two mathematical 
methods, as would be expected from distinct approaches to the diagnostic problem. 
Table 2 gives the ten most positive and ten most negative network weights and 
regression standardised weights. Examining this table leads to some interesting 
observations regarding the clinical picture, aetiology and epidemiology of CTS. The 
network and regression have three variables out of the top ten positive variables in 
common for predicting CTS, and seven out of the top ten negative variables for 
predicting non-CTS. There is agreement on greater age being the most predictive of 
CTS, also middle and ring finger distribution of symptoms and years since retirement 
increase the chance of CTS. The network includes five Boston variables among the 
top ten in favour of CTS, while the regression has none. Conversely, ex-smoker or 
lifelong non-smoker status is predictive of CTS in the regression model but not in the 
network. The appearance of smoking status in the regression model is somewhat 
unexpected, with lifelong non-smokers apparently being more likely to have CTS than 
ex-smokers who in turn seem to have a higher risk than current smokers. This is 
directly contrary to the findings of two previous epidemiological studies of risk 
factors for CTS.20,21 Of the seven common variables predicting non-CTS, Vibration 
white finger, Boston weakness on the right, and hours of keyboard activity have the 
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same ranking in the two models. Typically ulnar nerve distribution of symptoms, and 
height occupy the bottom two places in the list of negative weights against CTS, but 
in different orders for the two models. Occupational keyboard use making CTS less 
likely is contrary to much popular and occupational health perceived wisdom but is in 
agreement with two of the better recent studies of the issue.22,23 The differences 
between the two models may reflect the fact that most of the variables have only a 
small predictive value individually and the generation process for the neural network 
in particular includes some random elements so that, given a set of many roughly 
similar variables to choose from, a different set may be selected each time a network 
is trained. The presence of age as the strongest predictive factor in both models should 
remind us that CTS, frequently described as a disorder predominantly of middle aged 
women, is in fact very common in the elderly and frequently misdiagnosed. 
 
The regression model has selected more of the variables which would be familiar to 
the average clinician as markers of carpal tunnel syndrome – diurnal variation in 
symptoms, anatomical distribution of paraesthesiae, obesity, the last of these being 
striking in that, in the neural network model, the variable body mass index (BMI) 
which is dependent on height and weight, appears as a positive predictor while weight 
itself appears as a negative predictor. In the regression model this situation is reversed 
with weight appearing as a positive predictor and BMI as a negative one.  
 
We reviewed the case histories of a sample of patients who were mis-classified by 
both analytic methods. In the case of patients classified by the models as CTS who 
actually had normal nerve conduction studies it seemed likely that many of these were 
examples of false negative nerve conduction studies. 24/62 of these patients were 
evaluated by an experienced clinician (JDPB) as highly probable CTS on the evidence 
available at the time of assessment. Other recognisable groups of patients often 
misclassified by the models as CTS included those with ulnar nerve lesions at the 
elbow and patients with rheumatological disorders. The patients mis-classified as 
normal but having abnormal nerve conduction studies suggestive of CTS were much 
more heterogeneous but some of these patients clearly had dual pathology with the 
second condition dominating the clinical picture and in those with only 
neurophysiological evidence of CTS the clinical histories were often obviously 
atypical on review. 
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Despite our best efforts at including every possible clinical feature of the patient 
history which experienced clinicians use to make the diagnosis of CTS and the most 
sophisticated analysis tools available, it appears that none of these instruments 
achieve perfect prediction of NCS findings consistent with CTS. Why is this? Firstly 
we know that NCS will not always be right. Normality of nerve conduction studies is 
defined statistically in such a way that there will be a false positive rate, the 
magnitude of which is arbitrarily set by the cut-off values chosen. One would hope 
that a diagnostic tool would return the clinically „correct‟ answer in asymptomatic 
individuals with NCS measurements which just happen to lie outside the limits which 
have been set for normality, be that 2.5 standard deviations from a mean value, or 99th 
percentile. Disagreement between diagnostic instrument and NCS on these grounds is 
inevitable. Secondly we believe that NCS have a false negative rate but have no way 
of knowing what it is. Studies where clinical diagnosis is used as the gold standard for 
comparison give estimates ranging from 2-30%. Taking a successful outcome of 
surgery as a marker for the diagnosis suggests that the false negative rate is of the 
order of 5%. Whatever the actual figure, it is clear that these cases also should 
produce disagreement between a perfect clinical instrument and the 
neurophysiological diagnosis. A less considered issue is that of the accuracy of 
clinical diagnosis. A clinician‟s opinion is often held up as the definitive arbiter of 
whether a patient has CTS or not and, curiously, in this field this is rarely questioned. 
However, clinical diagnosis in other fields is manifestly not 100% accurate for many 
common disorders and there is no reason to believe that it is reliable for CTS. There 
are ample studies of failed treatment showing that initial diagnoses of CTS were 
incorrect, it subsequently becoming apparent that the patients had polyneuropathy, 
ulnar nerve lesions, cervical radiculopathy, rheumatological disorders, multiple 
sclerosis, syringomyelia or motor neurone disease.24 The 39% failure rate of surgery 
in Canterbury patients with normal NCS suggests that at least here, some patients get 
as far as surgery without the real cause of their symptoms having been established. If 
clinical diagnosis itself is not perfect then our diagnostic instruments, which are based 
upon the same input data, are also likely to be imperfect. There is no immediate 
prospect of a definitive diagnostic test becoming available which will allow both 
absolutely accurate diagnosis and the full evaluation of the performance of these other 
methods. However, the best units achieve success rates in treating CTS in excess of 
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98% patient satisfaction, probably through a combination of good patient selection 
and expert treatment. The use of formal tools may help less experienced clinicians to 
emulate this. 
 
The full questionnaire is too lengthy to include in a published paper and the 
mathematical models used to evaluate the answers are too complex for simple scoring 
on paper. We are therefore intending to make the entire questionnaire available online 
at www.carpal-tunnel.net - a non-commercial site created to host this tool.  
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FIGURE CAPTION 
 
Figure 1 
Receiver operating characteristic curves for the four different diagnostic tools 
evaluated, Kamath score (solid triangles, area under curve 0.63), original regression 
model (open diamonds, area under curve 0.73), current regression model (open 
squares, area under curve 0.79), artificial neural network (open circles, area under 
curve 0.79) 
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Table 1 
Predictors of Abnormal/Normal NCS consistent with CTS       
Ten most positive predictors        
Artificial Neural Network  Regression model       
Variable Weight Variable 
Standardised 
Weight, z 
95% CI 
for z 
Odds 
Ratio 
95% CI 
for OR 
Increasing age 3.23 Increasing age 9.26 7.3 11.22 1.05 1.04 1.06 
Boston numbness severity - R 1.41 Symptoms worse on driving 5.26 3.3 7.22 1.72 1.41 2.11 
Boston tingling severity - R 1.36 Symptoms worse first thing in morning 4.64 2.68 6.6 1.60 1.31 1.95 
Body mass index 1.29 Lifelong non-smoker 4.58 2.62 6.54 1.79 1.40 2.30 
No response to Diuretic 1.08 Middle and ring finger distribution 4.5 2.54 6.46 3.13 1.90 5.13 
Years since retirement 1.03 Thumb, index and middle finger distribution 4.47 2.51 6.43 2.63 1.72 4.01 
Boston telephone grip difficulty - L 1.01 Weight 3.32 1.36 5.28 1.09 1.03 1.14 
Middle and ring finger distribution 0.97 Self reported heavy manual work 3.12 1.16 5.08 1.64 1.20 2.25 
Boston night pain severity - R 0.91 Ex-smoker 2.99 1.03 4.95 1.46 1.14 1.88 
Boston book holding difficulty - R 0.90 Years since retirement 2.68 0.72 4.64 1.01 1.00 1.02 
         
Ten most negative predictors         
Artificial Neural Network  Regression Model       
Variable Weight Variable 
Standardised 
Weight 
     
Boston subjective weakness severity - L -1.00 Has never tried a wrist splint -2.47 -4.43 -0.51 0.67 0.49 0.92 
Boston day pain duration - R -1.01 Body mass index -2.66 -4.62 -0.7 0.83 0.73 0.95 
Boston grocery carrying difficulty -1.02 Raynaud's phenomenon -2.86 -4.82 -0.9 0.41 0.22 0.75 
Employment status - full time education -1.07 Boston day pain duration - R -2.96 -4.92 -1 0.70 0.55 0.88 
Vibration white finger -1.11 Vibration white finger -3.01 -4.97 -1.05 0.26 0.11 0.63 
Raynaud's phenomenon -1.17 Boston jar opening difficulty - L -3.1 -5.06 -1.14 0.73 0.59 0.89 
Boston weakness severity - R -1.36 Boston weakness severity - R -3.15 -5.11 -1.19 0.68 0.53 0.86 
Hours of keyboard use daily -1.57 Hours of keyboard use daily -3.75 -5.71 -1.79 0.92 0.88 0.96 
Height -1.62 Little and ring finger distribution -3.88 -5.84 -1.92 0.30 0.17 0.55 
Little and ring finger distribution -1.97 Height -4.29 -6.25 -2.33 0.90 0.86 0.94 
         
'Boston' variables are elements of the Boston/Levine CTS subjective severity assessment tool       
'R' and 'L' for these variables indicate the answers given for the right and left hands separately       
The Standardised Weights for the regression model are given instead of the raw weights since assessment of the statistical 
significance of a weight depends on the ratio of its raw value to its standard error (the Standardised Weight) 
     
Table 2 
 
Classification of new cases by the two methods   
     
  Artificial neural network  
    CTS Normal TOTAL 
NCS result CTS 1397 183 1580 
 Normal 518 518 1036 
 TOTAL 1915 701 2616 
  
Sensitivity 88.4%  
  
Specificity 50.0%  
  
   
  Regression model  
    CTS Normal TOTAL 
NCS result CTS 1127 453 1580 
 Normal 286 750 1036 
 TOTAL 1413 1203 2616 
  Sensitivity 71.3%  
  Specificity 72.4%  
McFadden‟s Pseudo R-squared value for the logistic regression model is 0.2962. 
ANN confusion matrix value is 0.3022 
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Table 3 
 
Classification of new cases by combination of both 
models   
     
  Questionnaire Evaluation  
    CTS Normal TOTAL 
NCS result CTS 1516 64 1580 
 Normal 518 518 1036 
 TOTAL 2034 582 2616 
  Sensitivity 95.9%  
  Specificity 50.0%  
Bland et al – Questionnaire diagnosis of CTS                                                 Page - 16 
Acronyms/Abbreviations 
 
CTS – Carpal Tunnel Syndrome 
NCS – Nerve conduction studies 
ANN – Artificial Neural Network 
LR – Logistic regression 
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